Head and neck

Predicting HPV+ Oropharyngeal Cancer Recurrence With Novel Biomarker
BY Allie Strickler
There is a need to find biomarkers that may help predict recurrence in HPV+ oropharyngeal cancer, says Matthew E. Spector, M.D.
SPOHNC Focuses on Support for Oral, Head and Neck Cancer
BY Allie Casey
From publications to one-on-one interactions, SPOHNC offers caregivers, patients and survivors of oral, head and neck cancer support they need to navigate their diagnosis.
In Managing the Emotional Challenges of Head and Neck Cancer, Communication is Key
BY Beth Fand Incollingo
CURE spoke with Carly O’Brien about some of the best tips and resources to deal with some of the challenges of head and neck cancer.
Checkpoint Inhibitors Expected to Play a Growing Role in Head and Neck Cancer Treatment
BY Beth Fand Incollingo
Immunotherapy agents are drastically changing the treatment landscape – and outcomes – of patients with head and neck cancers. 
A Stepped Approach to Psychosocial Care in Head and Neck Cancer Is Cost-Effective
BY Lauren M. Green
A four-step approach proved to be beneficial in offering psychosocial support to patients with head and neck cancer.
His Final Law: 21st Century Cures Act Signed by President Obama
BY Katie Kosko
President Barack Obama signed the 21st Century Cures Act into law, allocating more than $6 billion for precision medicine, research, drug abuse prevention and mental health over the next decade.
The Importance of Survivorship Care for Head and Neck Cancer
BY Brielle Urciuoli
Nurses at the Cleveland Clinic are pushing to make survivorship care the norm for survivors of head and neck cancer.
What's Next in Immunotherapy?
BY Christian M. Capitini, M.D.
Melanoma should not be considered to be in a "special category" that responds well to immunotherapy, according to Christian M. Capitini, M.D., assistant professor of Pediatrics at the University of Wisconsin.
Experts Discuss Immunotherapy's Role in the Shifting Landscape in Solid Tumors
A panel of experts recently discussed the evolving field of immunotherapy for solid tumor types.
New Combo Proves Highly Effective in Head and Neck Cancer
BY Silas Inman
The combination of lirilumab Opdivo proved to be effective for a subet of patients with head and neck cancer, according to a recent study.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Head-and-neck CURE discussion group.
Search Cancer Drugs & Terms
Supportive Care
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®)
Expert-reviewed information summary about oral complications, such as mucositis and salivary gland dysfunction, that occur in cancer patients treated with chemotherapy or radiation therapy to the head and neck.